The Russian market for blood clot prevention drugs continues its growth this year being one of the largest and most stable in ...

Japan’s Tanabe Pharma announced on Friday that the US Food and Drug Administration (FDA) has accepted for review the New Drug ...

US Food and Drug Administration (FDA) activity featured prominently in last week’s news, starting with approval of Scholar Rock’s Isembyld for spinal for spinal muscular atrophy. Then the agency went ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended 7 novel medicines for approval at its September 2026 meeting.

Global investment in longevity biotech reached a record $18.4 billion in 2025, up from $4.7 billion the year before, ...

Danish vaccine maker Bavarian Nordic (OMX: BAVA) has named Tarja Stenvall as president and chief executive with effect from October 15, closing a search that opened in March when Paul Chaplin said he ...

US pharma major Bristol Myers Squibb has stopped development of ORM-6151, a degrader-antibody conjugate (DAC) it licensed ...

US clinical-stage biotech Sironax announced that Novartis has exercised its exclusive option to acquire the full global ...

German family-owned pain specialist Grünenthal has priced 850 million euros ($974 million) of senior secured notes due 2032, ...

Danish pharma major Novo Nordisk (NOV: N) has struck a multi-target discovery and license agreement with fellow Copenhagen ...

San Diego-based medical device developer Aethlon Medical (Nasdaq: AEMD) has agreed an all-stock merger with privately held US ...

US biotech Scholar Rock announced that the US Food and Drug Administration (FDA) has approved Isembyld (apitegromab-mstn) for ...